Acorda Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.12 |
Market Cap |
$354.24 M |
Shares Outstanding |
48.13 M |
Public Float |
46.73 M |
Address |
420 Saw Mill River Road Ardsley New York 10502 United States |
Employees | - |
Website | http://www.acorda.com |
Updated | 07/08/2019 |
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. |